ProfileGDS5678 / 1443144_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 43% 30% 30% 28% 29% 35% 27% 29% 29% 29% 30% 29% 29% 29% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.0389743
GSM967853U87-EV human glioblastoma xenograft - Control 22.679730
GSM967854U87-EV human glioblastoma xenograft - Control 32.6748530
GSM967855U87-EV human glioblastoma xenograft - Control 42.5873328
GSM967856U87-EV human glioblastoma xenograft - Control 52.6155329
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.8811835
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.668427
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.644129
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.6320829
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.6419929
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.6772430
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.6354129
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.6514729
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.6537129